ARDX
Price
$5.55
Change
-$0.41 (-6.88%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
1.44B
34 days until earnings call
MYNDF
Price
$0.01
Change
-$0.02 (-66.67%)
Updated
Sep 9 closing price
Capitalization
659.88K
Interact to see
Advertisement

ARDX vs MYNDF

Header iconARDX vs MYNDF Comparison
Open Charts ARDX vs MYNDFBanner chart's image
Ardelyx
Price$5.55
Change-$0.41 (-6.88%)
Volume$138.86K
Capitalization1.44B
MYND Life Sciences
Price$0.01
Change-$0.02 (-66.67%)
Volume$9.89K
Capitalization659.88K
ARDX vs MYNDF Comparison Chart in %
Loading...
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARDX vs. MYNDF commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARDX is a Hold and MYNDF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ARDX: $5.55 vs. MYNDF: $0.01)
Brand notoriety: ARDX and MYNDF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARDX: 69% vs. MYNDF: 335%
Market capitalization -- ARDX: $1.44B vs. MYNDF: $659.88K
ARDX [@Biotechnology] is valued at $1.44B. MYNDF’s [@Biotechnology] market capitalization is $659.88K. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARDX’s FA Score shows that 0 FA rating(s) are green whileMYNDF’s FA Score has 1 green FA rating(s).

  • ARDX’s FA Score: 0 green, 5 red.
  • MYNDF’s FA Score: 1 green, 4 red.
According to our system of comparison, ARDX is a better buy in the long-term than MYNDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARDX’s TA Score shows that 5 TA indicator(s) are bullish while MYNDF’s TA Score has 4 bullish TA indicator(s).

  • ARDX’s TA Score: 5 bullish, 4 bearish.
  • MYNDF’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both ARDX and MYNDF are a good buy in the short-term.

Price Growth

ARDX (@Biotechnology) experienced а -10.63% price change this week, while MYNDF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

ARDX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARDX($1.44B) has a higher market cap than MYNDF($660K). ARDX YTD gains are higher at: 17.554 vs. MYNDF (-75.747).
ARDXMYNDFARDX / MYNDF
Capitalization1.44B660K217,576%
EBITDA-29.19MN/A-
Gain YTD17.554-75.747-23%
P/E RatioN/AN/A-
Revenue386MN/A-
Total Cash238MN/A-
Total Debt207MN/A-
FUNDAMENTALS RATINGS
ARDX: Fundamental Ratings
ARDX
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
41
SEASONALITY SCORE
1..100
35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARDXMYNDF
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
27%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
38%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
39%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
39%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
52%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
38%
Advances
ODDS (%)
Bullish Trend 16 days ago
87%
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
81%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
44%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRZRX17.000.02
+0.12%
T. Rowe Price Real Assets Z
AIECX19.86N/A
N/A
Invesco EQV International Equity C
KCGIX24.50N/A
N/A
Knights of Columbus Large Cap Growth I
GWSAX17.34N/A
N/A
Gabelli Focused Gr and Inc A
NFACX33.51-0.28
-0.83%
Neuberger Berman Focus C

ARDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARDX has been loosely correlated with RIGL. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ARDX jumps, then RIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARDX
1D Price
Change %
ARDX100%
-3.09%
RIGL - ARDX
37%
Loosely correlated
-5.22%
PCVX - ARDX
34%
Loosely correlated
-2.07%
MYNDF - ARDX
33%
Loosely correlated
N/A
MAIA - ARDX
31%
Poorly correlated
-1.87%
CLRB - ARDX
31%
Poorly correlated
-0.52%
More

MYNDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNDF has been loosely correlated with ARDX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNDF jumps, then ARDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNDF
1D Price
Change %
MYNDF100%
N/A
ARDX - MYNDF
33%
Loosely correlated
-6.88%
AMLX - MYNDF
32%
Poorly correlated
+5.21%
RNAC - MYNDF
28%
Poorly correlated
-2.43%
TNYA - MYNDF
24%
Poorly correlated
+11.41%
ICCC - MYNDF
24%
Poorly correlated
-0.08%
More